Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome

PHASE3CompletedINTERVENTIONAL
Enrollment

564

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

June 30, 2013

Conditions
Dry Eye Syndrome
Interventions
DRUG

Rebamipide 2% ophthalmic suspension

Instill one drop into each eye 4 times a day for 4 weeks.

DRUG

Placebo (vehicle)

Instill one drop into each eye 4 times a day for 4 weeks.

Trial Locations (34)

Unknown

Phoenix

Little Rock

Artesia

Glendale

Inglewood

San Diego

Wheat Ridge

Fort Myers

Miami

Plantation

Stuart

Tampa

Morrow

Baton Rouge

Lutherville

Kansas City

St Louis

Washington

Las Vegas

Princeton

Rochester

Rockville Centre

Valley Stream

Wantagh

Ashville

Charlotte

Cleveland

Mason

Pittsburgh

Chattanooga

Memphis

Houston

Salt Lake City

Norfolk

Sponsors
All Listed Sponsors
collaborator

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY

lead

Kubota Vision Inc.

INDUSTRY